Somerville, NJ, United States of America

Richard Gerald Wilde

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 7.5

ph-index = 6

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2007-2021

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: The Innovative Contributions of Richard Gerald Wilde from Somerville, NJ

Introduction

Richard Gerald Wilde, a notable inventor based in Somerville, New Jersey, has made significant contributions to the field of cancer research through his innovative work. With an impressive portfolio of 21 patents, Wilde has dedicated his career to developing novel compounds aimed at inhibiting specific proteins implicated in cancer progression.

Latest Patents

Richard Wilde's most recent patents showcase his focus on B-cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein inhibitors. His first patent, titled "Substituted Reverse Pyrimidine Bmi-1 Inhibitors," describes amine substituted reverse pyrimidine compounds that inhibit the function and reduce the levels of the Bmi-1 protein. These compounds have promising applications in treating cancers mediated by Bmi-1. Furthermore, Wilde's patent on "Substituted Pyridine and Pyrazine Bmi-1 Inhibitors" outlines similar amine substituted compounds that serve the same purpose, emphasizing his commitment to discovering effective cancer treatment methodologies.

Career Highlights

Throughout his career, Wilde has worked with several esteemed companies, including PTC Therapeutics, Inc. and Amgen Inc. His contributions to the field of oncology and pharmaceutical development have been influential, particularly in understanding how to mitigate the effects of harmful proteins involved in cancer.

Collaborations

Collaboration has been key to Wilde's success as an inventor. He has worked alongside fellow researchers such as James Jan Takasugi and Hongyu Ren, enhancing the impact of their collective work on cancer therapeutics and the development of innovative treatments.

Conclusion

Richard Gerald Wilde continues to be a leading figure in the fight against cancer, with a robust portfolio of patents that reflect his dedication and innovative spirit. His ongoing research and collaboration with industry peers promise to bring forth additional breakthroughs in the realm of cancer treatment, reinforcing the importance of his work in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…